Clinical Trials Sponsored by Meddoc

Total 324 results

Meddoc

Completed

Response Surface Pathway Design With Two Interventional- and One Response Variable in Estimating Minimum Efficacy Dose

GERD
Meddoc

Recruiting

Validation of Bulbicam for Parkinson- and Ataxia-patients

Parkinson Disease | Ataxia

Norway
Meddoc

Recruiting

Bulbicam Validation on Glaucoma- and Cataract Patients

Cataract | Glaucoma Eye

Norway
Meddoc
Tine

Completed

Dose Estimation of Jarlsberg Cheese in Young, Active Norwegian Cross-country Skiers (XCS)

Healthy Nutrition

Norway
Meddoc
Tine

Not yet recruiting

The Long-term Effect of Daily Jarlsberg Cheese Intake in Patient With Osteopenia (PF-JB3)

Osteoporosis | Osteopenia
Meddoc
Tine

Recruiting

Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female (HV-ID)

Healthy Aging

Norway
Meddoc
Meabco A/S

Not yet recruiting

Recommended Dose Estimation of BP-C2

Prostate Cancer
Meddoc
Oslo University Hospital

Recruiting

Validation of Bulbicam for DR- and AMD-patients

Age-Related Macular Degeneration | Diabetic Retinopathy

Norway
Meabco A/S
Meddoc; Norwegian University of Life Sciences; Meddoc Research Indonesia Ltd; Meddoc...

Completed

Dose-finding Study of BP-C1 in Patients With Stage IV Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer

Taiwan, Thailand, Indonesia
Prof Stig Larsen
Tine

Completed

Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese

Diabetes | Cancer | Liver Disease | Heathy Women | Pre Menopausal Age | Exlution Criteria: Gastrointestinal Disorder | Kidney Disorder

Norway
Meddoc
The Research Council of Norway; Tine

Recruiting

Profylactic Treatment for Patients in Risk Osteoporosis (PF-Jarlsberg)

Osteopenia or Osteoporosis

Norway
Meddoc
Tine; Norwegian University of Life Sciences

Completed

Estimation of a Maintaining Daily Jarlsberg Cheese-dose

Osteocalcin | Vitamin K Deficiency | Maintenance Dose

Norway
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer

Thailand, Russian Federation
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 Monotherapy in Patients With Metastatic Breast Cancer Cancer: Estimation of Optimal Duration of Treatment

Metastatic Breast Cancer | Stage IV Breast Cancer

Thailand, Russian Federation
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer

Metastatic Pancreatic Cancer | Unresectable Pancreatic Cancer

Egypt
Meabco A/S
Meddoc; Norwegian University of Life Sciences

Completed

BP-C1 in Short-term Treatment of Thai Patients With Metastatic Breast Cancer

Metastatic Breast Cancer | Stage IV Breast Cancer

Thailand
Centro Medico Teknon

Recruiting

Personalized Persistent Atrial Fibrillation Ablation: The PeAF-by-LAWT Trial (PeAF-by-LAWT)

Persistent Atrial Fibrillation | Persistent Atrial Fibrillation Longstanding

Spain
Centro Medico Teknon

Recruiting

Mobile Electrocardiogram Monitoring for Detecting Arrhythmias in Children

Arrhythmias, Cardiac | Congenital Heart Disease | Diagnoses Disease | Sudden Cardiac Death | Children, Only

Spain
Medeor Therapeutics, Inc.

Not yet recruiting

Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

Kidney Transplant Rejection
Centro Medico Teknon

Completed

Long-term outcomeS of cavotrIcuspid isthMus-dePendent fLuttEr Ablation: Single vs Double Catheter Procedure

Atrial Flutter

Spain
Centro Medico ABC

Terminated

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

Covid-19

Mexico
Medeon Biodesign, Inc.

Completed

Clinical Study of the Medeon Biodesign XPro™

Percutaneous Closure of Arteriotomy in Common Femoral Artery

Taiwan, New Zealand, Australia
MedDay Pharmaceuticals SA

Completed

Effect of MD1003 in Amyotrophic Lateral Sclerosis (MD1003-ALS)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | ALS

France
Centro Medico Teknon

Completed

Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)

Fibromyalgia | Growth Hormone Deficiency

Spain
Medeor Therapeutics, Inc.

Recruiting

Long-term Safety Follow-up in Recipients Who Previously Received Medeor's Cellular Immunotherapy Products

Immune Tolerance

United States
Centro Medico Teknon

Recruiting

Preventive VT Substrate Ablation in Ischemic Heart Disease (PREVENT-VT)

Myocardial Infarction | Ischemic Heart Disease | Ventricular Tachycardia | Magnetic Resonance Imaging | Ventricular Arrythmia | Sudden Cardiac Death | Sudden Cardiac Death Due to Cardiac Arrhythmia

Spain
Centro Medico Teknon

Recruiting

CMR Based Prediction of Ventricular Tachycardia Events in Healed Myocardial Infarction (DEVELOP-VT) (DEVELOP-VT)

Myocardial Infarction | Arrhythmias, Cardiac | Ventricular Tachycardia | Ventricular Arrythmia | Sudden Cardiac Death | Myocardial Infarction Old | Sudden Cardiac Death Due to Cardiac Arrhythmia

Spain
Centro Medico Teknon

Recruiting

Maxillomandibular Advancement in the Treatment of Obstructive Sleep Apnea

OSA | Orthognathic Surgery | Apnea, Obstructive Sleep | OSAS

Spain
Medeor Therapeutics, Inc.

Not yet recruiting

Cellular Immunotherapy for Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kidney Transplants

Kidney Transplant Rejection
Centro Medico Teknon

Completed

Relationship Between the Posterior Atrial Wall and the Esophagus: Esophageal Position and Temperature MEasurement During Atrial Fibrillation Ablation. (AWESOME-AF)

Atrial Arrhythmia

Spain
MedDay Pharmaceuticals SA

Completed

SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study

Charcot-Marie-Tooth Disease | Peripheral Neuropathy | Chronic Inflammatory Demyelinating Polyneuropathy | Charcot-Marie-Tooth Disease Type 1A | Charcot-Marie-Tooth Disease, Type 1B | Anti-MAG Neuropathy

France
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis (MS-ON)

Multiple Sclerosis

United Kingdom, France
MedDay Pharmaceuticals SA

Unknown

Effect of MD1003 in Spinal Progressive Multiple Sclerosis (MS-SPI)

Multiple Sclerosis

France
Centro Medico Polispecialistico

Not yet recruiting

Clinical Study on Hyaluronic Acid With Lidocaine for the Treatment of Moderate to Severe Nasolabial Folds

Nasolabial Folds
MedDay Pharmaceuticals SA

Terminated

Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (SPI2)

Multiple Sclerosis

United States, Spain, Canada, Australia, United Kingdom, Belgium, Turkey, Czechia, Poland, Italy, Hungary, Germany, Sweden
Centro Medico Teknon

Completed

MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation (MANIaC-PVC)

Ventricular Premature Complexes | Catheter Ablation

Spain
MedDay Pharmaceuticals SA

Completed

MD1003-AMN MD1003 in Adrenomyeloneuropathy

Adrenoleukodystrophy | Adrenomyeloneuropathy | AMN

France, Germany, Spain
Centro Medico Campinas

Completed

Efficacy of S(+)-Ketamine Administered as a Continuous Infusion for the Control of Postoperative Pain

Postoperative Pain

Brazil
Centro Medico Campinas

Unknown

Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty

Hemolysis

Brazil
medac GmbH

Not yet recruiting

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Moderate to Severe Atopic Dermatitis
medac GmbH

Completed

Dose-range Finding Treosulfan-based Conditioning

Hematological Malignancies

Germany, Finland, Poland, Sweden
medac GmbH

Completed

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Germany, Italy, Poland, France, Finland, Hungary
medac GmbH

Terminated

Urokinase Therapy in Patients With Diabetic Foot Syndrome

Ischemia | Diabetic Foot | Arterial Occlusive Disease

Germany
medac GmbH

Completed

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

Brain Cancer | Brain Tumors | Brain Tumor, Primary | Primary Brain Tumors | Cancer of Brain
medac GmbH

Completed

Urokinase Therapy in Diabetic Foot Syndrome

Ischemia | Diabetic Foot | Arterial Occlusive Disease

Germany
medac GmbH

Recruiting

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease (BALDER)

Steroid-refractory Acute Graft-versus-host Disease

Germany, Spain, France, Poland
medac GmbH

Terminated

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia

Germany
medac GmbH

Completed

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome

Finland
medac GmbH

Recruiting

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy (IDUNN)

Steroid-refractory Acute Graft-versus-host Disease

Spain, Germany, France, Poland, Sweden
medac GmbH

Completed

Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Germany

Clinical Trials Sponsored by Meddoc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations